Amgen saw the highest growth of 98% in patent filings in August and 130% in grants in September in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 86% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Amgen‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Amgen has been focused on protecting inventions in European Patent Office (EPO) with 91 publications in Q3 2023

The EPO dominates the patent filings and grants with nearly 16% filings and 17% grants. The EPO, United States(US), Australia(AU), and Japan(JP) patent Office are among the top ten patent offices where Amgen is filings its patents. Among the top granted patent authorities, Amgen has 19% of its grants in United States(US), 17% in the EPO, and 13% in Canada(CA).

Johnson & Johnson could be the strongest competitor for Amgen

In terms of grant share, Amgen stands in fifth position among its competitors. Johnson & Johnson and Pfizer secured the top positions according to recent patent publication data.

Patents related to rare diseases and data science lead Amgen's portfolio

Amgen has the highest number of patents in rare diseases followed by, data science and artificial intelligence. For rare diseases, nearly 29% of patents were filed and 39% of patents were granted in Q3 2023.

Drug delivery devices related patents lead Amgen portfolio followed by pancreatic cancer, and lung cancer

Amgen has highest number of patents in drug delivery devices followed by pancreatic cancer, lung cancer, colorectal tumor and rheumatoid arthritis. For drug delivery devices, nearly 4% of patents were filed and 4% of patents were granted in Q3 2023.

For comprehensive analysis of Amgen's filings and grants, buy the databook here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.